CAPTRUST Financial Advisors’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-75,000
Closed -$34K 2252
2022
Q3
$34K Buy
75,000
+17,024
+29% +$8.83K ﹤0.01% 2004
2022
Q2
$29K Buy
57,976
+1,000
+2% +$489 ﹤0.01% 3160
2022
Q1
$30K Hold
56,976
﹤0.01% 3156
2021
Q4
$36K Hold
56,976
﹤0.01% 2909
2021
Q3
$87K Hold
56,976
﹤0.01% 2186
2021
Q2
$97K Hold
56,976
﹤0.01% 2059
2021
Q1
$97K Buy
56,976
+49,926
+708% +$112K ﹤0.01% 1978
2020
Q4
$12K Sell
7,050
-33
-0.5% -$33 ﹤0.01% 2497
2020
Q3
$5K Hold
7,083
﹤0.01% 2555
2020
Q2
$6K Buy
+7,083
New +$3.63K ﹤0.01% 2366
2019
Q4
Sell
-83
Closed 1931
2019
Q3
$0 Hold
83
﹤0.01% 2046
2019
Q2
$0 Hold
83
﹤0.01% 2035
2019
Q1
$0 Hold
83
﹤0.01% 1914
2018
Q4
$0 Hold
83
﹤0.01% 1703
2018
Q3
$0 Hold
83
﹤0.01% 1737
2018
Q2
$0 Buy
+83
New +$499 ﹤0.01% 1631

Other funds holding TMDI

CAPTRUST Financial Advisors's TMDI Position: Q4 2022 in Review

CAPTRUST Financial Advisors sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q4 2022, closing a stake of 75,000 shares — an estimated $34K sold.

CAPTRUST Financial Advisors first reported a position in TMDI in Q2 2018 and held it in 16 quarters. The position peaked at $97K in Q2 2021. 71 funds tracked by Wall St. Rank hold TMDI as of Q4 2022.

  • CAPTRUST Financial Advisors reported no remaining Titan Medical Inc. Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 75,000 Titan Medical Inc. Ordinary Shares shares in Q4 2022, an estimated $34K.
  • CAPTRUST Financial Advisors first reported a position in Titan Medical Inc. Ordinary Shares in Q2 2018 and held it in 16 quarters.
  • CAPTRUST Financial Advisors's Titan Medical Inc. Ordinary Shares position peaked at $97K in Q2 2021.
  • 71 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q4 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.